Literature DB >> 29601082

Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.

M Navidi1, A W Phillips1, S M Griffin1, K E Duffield2, A Greystoke3, K Sumpter3, R C F Sinclair2.   

Abstract

BACKGROUND: Neoadjuvant chemotherapy may have a detrimental impact on cardiorespiratory reserve. Determination of oxygen uptake at the anaerobic threshold by cardiopulmonary exercise testing (CPET) provides an objective measure of cardiorespiratory reserve. Anaerobic threshold can be used to predict perioperative risk. A low anaerobic threshold is associated with increased morbidity after oesophagogastrectomy. The aim of this study was to establish whether neoadjuvant chemotherapy has an adverse effect on fitness, and whether there is recovery of fitness before surgery for oesophageal and gastric adenocarcinoma.
METHODS: CPET was completed before, immediately after (week 0), and at 2 and 4 weeks after neoadjuvant chemotherapy. The ventilatory anaerobic threshold and peak oxygen uptake (Vo2 peak) were used as objective, reproducible measures of cardiorespiratory reserve. Anaerobic threshold and Vo2 peak were compared before and after neoadjuvant chemotherapy, and at the three time intervals.
RESULTS: Some 31 patients were recruited. The mean anaerobic threshold was lower following neoadjuvant treatment: 15·3 ml per kg per min before chemotherapy versus 11·8, 12·1 and 12·6 ml per kg per min at week 0, 2 and 4 respectively (P < 0·010). Measurements were also significantly different at each time point (P < 0·010). The same pattern was noted for Vo2 peak between values before chemotherapy (21·7 ml per kg per min) and at weeks 0, 2 and 4 (17·5, 18·6 and 19·3 ml per kg per min respectively) (P < 0·010). The reduction in anaerobic threshold and Vo2 peak did not improve during the time between completion of neoadjuvant chemotherapy and surgery.
CONCLUSION: There was a decrease in cardiorespiratory reserve immediately after neoadjuvant chemotherapy that was sustained up to the point of surgery at 4 weeks after chemotherapy.
© 2018 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29601082     DOI: 10.1002/bjs.10802

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Multimodal exercise ameliorates exercise responses and body composition in head and neck cancer patients receiving chemotherapy.

Authors:  Chia-Jui Yen; Ching-Hsia Hung; Chung-Lan Kao; Wei-Ming Tsai; Shih-Hung Chan; Hui-Ching Cheng; Wan-Ting Jheng; Yan-Jhen Lu; Kun-Ling Tsai
Journal:  Support Care Cancer       Date:  2019-04-04       Impact factor: 3.603

2.  Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life-A Pilot Randomized Clinical Trial.

Authors:  Sophie K Allen; Vanessa Brown; Daniel White; David King; Julie Hunt; Joe Wainwright; Annabelle Emery; Emily Hodge; Aga Kehinde; Pradeep Prabhu; Timothy A Rockall; Shaun R Preston; Javed Sultan
Journal:  Ann Surg Oncol       Date:  2021-11-01       Impact factor: 5.344

3.  A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocol.

Authors:  J Chmelo; A W Phillips; A Greystoke; S J Charman; L Avery; K Hallsworth; J Welford; R C F Sinclair
Journal:  Pilot Feasibility Stud       Date:  2020-04-23

4.  Use of a Perioperative Web-Based Exercise Program for a Patient with Barrett's Carcinoma Scheduled for Esophagectomy.

Authors:  Barlo Hillen; Perikles Simon; Peter P Grimminger; Ines Gockel; Daniel Pfirrmann
Journal:  Case Rep Oncol       Date:  2019-10-09

5.  The effects of cancer therapies on physical fitness before oesophagogastric cancer surgery: a prospective, blinded, multi-centre, observational, cohort study [version 1; peer review: 2 approved].

Authors:  Malcolm A West; Zachos Anastasiou; Gareth Ambler; Lisa Loughney; Michael G Mythen; Thomas Owen; Gerard Danjoux; Denny Z H Levett; Peter M A Calverley; Jamie J Kelly; Sandy Jack; Michael P W Grocott
Journal:  NIHR Open Res       Date:  2021-06-16

Review 6.  Multiphasic Prehabilitation Across the Cancer Continuum: A Narrative Review and Conceptual Framework.

Authors:  Daniel Santa Mina; Stefanus J van Rooijen; Enrico M Minnella; Shabbir M H Alibhai; Priya Brahmbhatt; Susanne O Dalton; Chelsia Gillis; Michael P W Grocott; Doris Howell; Ian M Randall; Catherine M Sabiston; Julie K Silver; Gerrit Slooter; Malcolm West; Sandy Jack; Franco Carli
Journal:  Front Oncol       Date:  2021-01-11       Impact factor: 6.244

7.  Evolution of Esophagectomy for Cancer Over 30 Years: Changes in Presentation, Management and Outcomes.

Authors:  S Michael Griffin; Rhys Jones; Sivesh Kathir Kamarajah; Maziar Navidi; Shajahan Wahed; Arul Immanuel; Nick Hayes; Alexander W Phillips
Journal:  Ann Surg Oncol       Date:  2020-10-18       Impact factor: 5.344

Review 8.  The Role of Cardiopulmonary Exercise Testing as a Risk Assessment Tool in Patients Undergoing Oesophagectomy: A Systematic Review and Meta-analysis.

Authors:  Jonathan Sivakumar; Harry Sivakumar; Matthew Read; Rhona C F Sinclair; Chistopher P Snowden; Michael W Hii
Journal:  Ann Surg Oncol       Date:  2020-06-02       Impact factor: 5.344

9.  Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction.

Authors:  S K Kamarajah; M Navidi; S Wahed; A Immanuel; N Hayes; S M Griffin; A W Phillips
Journal:  Ann Surg Oncol       Date:  2020-03-21       Impact factor: 5.344

10.  Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study.

Authors:  C Simonsen; S Thorsen-Streit; A Sundberg; S S Djurhuus; C E Mortensen; C Qvortrup; B K Pedersen; L B Svendsen; P de Heer; J F Christensen
Journal:  BJS Open       Date:  2020-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.